Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the development of ...
Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that ...
The Global Sepsis Diagnostics Market size, valued at USD 1,133.2 million in 2018, grew substantially to USD 1,790.9 million ...
TipRanks on MSN
Co-Diagnostics Announces $7M Securities Purchase Agreement
Co-Diagnostics ( ($CODX) ) has issued an announcement. On October 28, 2025, Co-Diagnostics, Inc. announced a Securities Purchase Agreement with ...
Data originates at the edge, and processing it locally unlocks powerful real-time efficiencies that open very rich product ...
An international team of scientists from three continents led by Dr. Petr Cígler of IOCB Prague has developed a method for ...
4don MSN
Innovative diagnostic method brings fast and affordable pneumonia detection to low-resource settings
Pneumonia remains one of the leading causes of death in low- and middle-income countries, where access to advanced medical ...
Adelaide researchers have identified a promising new biomarker and treatment target for ovarian cancer that could markedly ...
Mina is a molecular biology major and plans to become an oncologist, with a focus on improving access to care.
Autonomous micro- and nanomotors improve image clarity, targeting, and multimodal performance across advanced biomedical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback